Literature DB >> 7973436

Hepatobiliary disease in ulcerative colitis. An analysis of 18 patients with hepatobiliary lesions classified as small-duct primary sclerosing cholangitis.

K M Boberg1, E Schrumpf, O Fausa, K Elgjo, F Kolmannskog, T Haaland, E Holter.   

Abstract

BACKGROUND: The aim of the present study was to describe the characteristics of patients with ulcerative colitis (UC) and hepatobiliary disease that does not satisfy the diagnostic cholangiographic criteria of primary sclerosing cholangitis (PSC) and to compare this group with PSC patients.
METHODS: Among 199 patients with UC admitted to our department during 1986-91, 64 patients had major hepatobiliary disease considered to be associated with the colitis. Biochemical tests, colonoscopy, endoscopic retrograde cholangiography (ERC), and liver biopsy were performed in these 64 patients and in 5 patients from our outpatient clinic.
RESULTS: PSC was diagnosed in 51 patients (group I; 80%). The other 13 patients (20%) and the additional 5 patients (n = 18; group II) all had normal extrahepatic bile ducts. Five patients in group II also had normal intrahepatic ducts, whereas 13 patients had intrahepatic abnormalities. The male to female ratio in group II was 2.0:1. All of them had extensive colitis. The clinical symptoms and the biochemical and histologic findings were quite similar in groups I and II.
CONCLUSIONS: The patients in group II of this study constitute a major group with hepatobiliary lesions associated with UC, amounting to one-fourth the number of PSC patients. They have several similarities with classical PSC of the large bile ducts, and we suggest that they be classified as having small-duct PSC.

Entities:  

Mesh:

Year:  1994        PMID: 7973436     DOI: 10.3109/00365529409092504

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  8 in total

Review 1.  Diffuse intrahepatic biliary strictures in sarcoidosis resembling sclerosing cholangitis. Case report and review of the literature.

Authors:  I Alam; S D Levenson; L D Ferrell; N M Bass
Journal:  Dig Dis Sci       Date:  1997-06       Impact factor: 3.199

2.  Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis.

Authors:  E Björnsson; K M Boberg; S Cullen; K Fleming; O P Clausen; O Fausa; E Schrumpf; R W Chapman
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

3.  Small-duct primary sclerosing cholangitis. A single-center seven-year experience.

Authors:  Nikolaos L Nikolaidis; Olga I Giouleme; Konstantinos A Tziomalos; Kalliopi Patsiaoura; Eirini Kazantzidou; Anastasios D Voutsas; Themistoklis Vassiliadis; Nikolaos P Eugenidis
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

4.  Epidemiology of appendicectomy in primary sclerosing cholangitis and ulcerative colitis: its influence on the clinical behaviour of these diseases.

Authors:  T H J Florin; N Pandeya; G L Radford-Smith
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

Review 5.  Clinical features and management of primary sclerosing cholangitis.

Authors:  Marina-G Silveira; Keith-D Lindor
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

6.  Primary sclerosing cholangitis.

Authors:  Joy Worthington; Roger Chapman
Journal:  Orphanet J Rare Dis       Date:  2006-10-24       Impact factor: 4.123

7.  Small Duct Primary Sclerosing Cholangitis in Association With Hepatitis C Virus Infection: A Case Report.

Authors:  Suresh Kumar Nayudu; Kavitha Kumbum; Bhavna Balar; Masooma Niazi; Sridhar Chilimuri
Journal:  Gastroenterology Res       Date:  2011-01-20

8.  Clinical guidelines for primary sclerosing cholangitis 2017.

Authors:  Hiroyuki Isayama; Susumu Tazuma; Norihiro Kokudo; Atsushi Tanaka; Toshio Tsuyuguchi; Takahiro Nakazawa; Kenji Notohara; Suguru Mizuno; Nobuhisa Akamatsu; Masahiro Serikawa; Itaru Naitoh; Yoshiki Hirooka; Toshifumi Wakai; Takao Itoi; Tomoki Ebata; Shinji Okaniwa; Terumi Kamisawa; Hiroki Kawashima; Atsushi Kanno; Keiichi Kubota; Masami Tabata; Michiaki Unno; Hajime Takikawa
Journal:  J Gastroenterol       Date:  2018-06-27       Impact factor: 7.527

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.